Trinity Capital Inc. (NASDAQ:TRIN) Announces Monthly Dividend of $0.17

Posted by Brian Himes on Jun 18th, 2026

Trinity Capital Inc. (NASDAQ:TRIN – Get Free Report) declared a monthly dividend on Wednesday, June 17th. Investors of record on Thursday, September 10th will be given a dividend of 0.17 per share on Wednesday, September 30th. This represents a c) annualized dividend and a dividend yield of 12.2%. The ex-dividend date of this dividend is Thursday, September 10th.

Trinity Capital has a dividend payout ratio of 100.0% meaning its dividend is currently covered by earnings, but may not be in the future if the company’s earnings fall. Equities analysts expect Trinity Capital to earn $2.12 per share next year, which means the company should continue to be able to cover its $2.04 annual dividend with an expected future payout ratio of 96.2%.

Trinity Capital Trading Down 0.8%

Shares of Trinity Capital stock opened at $16.77 on Thursday. The firm has a market capitalization of $1.51 billion, a PE ratio of 8.87 and a beta of 0.62. Trinity Capital has a twelve month low of $13.76 and a twelve month high of $17.38. The firm’s 50-day moving average price is $16.48 and its 200 day moving average price is $15.73.

Trinity Capital (NASDAQ:TRIN – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.52 by $0.01. Trinity Capital had a return on equity of 14.94% and a net margin of 43.45%.The company had revenue of $51.37 million during the quarter, compared to analyst estimates of $85.87 million. On average, sell-side analysts predict that Trinity Capital will post 2.1 EPS for the current fiscal year.

About Trinity Capital

(Get Free Report)

Trinity Capital Corporation (NASDAQ: TRIN) is a publicly traded business development company that provides flexible financing solutions to venture-backed and growth-stage companies. As a venture lender, Trinity Capital offers customized capital structures, including secured debt and equity co-investment, designed to support companies that have progressed beyond early-stage funding but still require non-dilutive growth capital.

The company focuses its investments on technology-driven sectors such as software, fintech, healthcare, life sciences and cleantech.